Impact of pathogenic and likely pathogenic variants of genes with high and moderate penetrance (BRCA1, BRCA2, PTEN, TP53, ATM, CHEK2, PALB2, CDH1) on clinical-pathological features and outcome in early breast cancer patients- Real-world data from single institution